Steve Edward Krognes
Independent DirectorMr. Steve Edward Krognes, M.B.A. serves as Director of Alveus Therapeutics ApS from April 2026. Mr. Krognes is an Independent Director of Pliant Therapeutics, Inc. since June 2024. Mr. Krognes serves as Independent Non-Executive Director at argenx SE since February 27, 2023. He serves as Chairman of the Board of Directors of Tessa Therapeutics Inc. since January 2023. He has been Director of Tessa Therapeutics Pte Ltd. since September 2022 and serves as its Chairman. Mr. Krognes had been a Director of Denali Therapeutics Inc. since May 01, 2022 until May 1, 2025 and serves as its Independent Director since May 1, 2025. He had been an Independent Director of Gritstone bio, Inc. (formerly known as Gritstone Oncology, Inc.) since July 2018 until 2024. He is an Independent Director of Guardant Health, Inc. from June 30, 2022. Mr. Krognes had been Chief Financial Officer of Denali Therapeutics Inc. since October 10, 2015 until April 30, 2022 and had been its Treasurer since November 2015 until April 30, 2022. Mr. Krognes served as Senior Vice President, Regional Head of Finance & IT and Chief Financial Officer of Pharma North America at Genentech, Inc. from April 2009 to September 2015. Mr. Krognes also oversaw Genentech’s site services organization from 2011 to 2015 and Genentech’s information technology organization from 2009 to 2011. He Chaired the Genentech Access to Care Foundation from 2009 to 2015. From April 2000 to June 2002, he was a venture capitalist with Pylonia Ventures, a Swedish venture investments company. He served as Independent Chairman at RLS Global AB (publ) since 2021 and served as Member of the Board since August 1, 2016 until 2023. Mr. Krognes served as Executive Vice President and Chief Financial Officer of Genentech, Inc. He joined Roche in January 2004 and served as its Global Head of Mergers and Acquisitions from January 2004 to April 2009. He served as Head of Corporate Finance-Corporate Development of Roche Holding AG. In this role, he led Roche's internal Mergers and Acquisitions group and was responsible for all Roche transactions worldwide. He worked as a venture capitalist in Scandinavia, as a mergers and acquisitions investment banker with Goldman Sachs and Danske Bank and as a management consultant with McKinsey & Co. From July 2002 to December 2003, Mr. Krognes served as Director of M&A at Danske Bank based in Norway. Mr. Krognes served as a Board Member of the California Life Science Association from 2010 to 2015 and California Academy of Sciences from 2014 to 2018. He had been an Independent Director of Corvus Pharmaceuticals, Inc. since January 2016 until 2020. He was a Director of California Life Sciences Association since August 2010 until 2015. He is a second lieutenant in the Royal Norwegian Air Force. Mr. Krognes serves on the board of ClavystBio. Mr. Krognes holds a Master's in Business Administration from the Harvard Business School and a B. S. in Economics at the Wharton School at the University of Pennsylvania.
Positions
- Company NameGuardant Health, Inc.Stock CodeGHPositionIndependent DirectorColleagues
